Yanhong Deng, PhD
Sixth Affiliated Hospital, Sun Yat-sen University · Sun Yat-sen University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yanhong Deng, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:52 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07729605 · FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRCSun Yat-sen University · not yet recruiting · Colorectal Cancer Metastatic, Microsatellite Stable (MSS) Colorectal Cancer (CRC) · principal investigator
- Ph1/Ph2NCT06434090 · Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal CancerSun Yat-sen University · unknown · Colorectal Cancer · principal investigator
- Ph2NCT02887313 · FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World StudySun Yat-sen University · unknown · Rectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.